The objective of this study was to evaluate the treatment outcome of c
hildren with acute leukemias at a university hospital in Singapore. Be
tween January 1988 and January 1994, 66 children were treated, compris
ing 13 cases of acute myeloid leukemia (AML) and 53 of acute lymphobla
stic leukemia (ALL). The 2-year disease-free survival (DFS) was comput
ed according to the Kaplan-Meier method. The results showed that the s
urvival for AML was poor, with a 2-year DFS of only 30%. The major cau
se of death for AML was leukemia and leukemia-related complications, s
uch as hemorrhage and severe infections. In contrast, a 62% 2-year DFS
was achieved for ALL. It was found that marked hepatosplenomegaly (en
larged liver and/or spleen greater than or equal to 10 cm below the co
stal margin) at presentation correlated with a significantly shortened
survival in our patients with ALL. The major cause for treatment fail
ure in ALL was recurrence of disease. We conclude that the DFS for our
patients with ALL at 2 years was fair. The treatment results for AML
were poor, but the numbers are too small to make any definite conclusi
ons. (C) 1996 Wiley-Liss, Inc.